101 related articles for article (PubMed ID: 12873649)
1. Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely.
Yan Y; Hoover DR; Moore RD; Xiong C
J Clin Epidemiol; 2003 Jun; 56(6):546-52. PubMed ID: 12873649
[TBL] [Abstract][Full Text] [Related]
2. Competing risk adjustment reduces overestimation of opportunistic infection rates in AIDS.
Yan Y; Moore RD; Hoover DR
J Clin Epidemiol; 2000 Aug; 53(8):817-22. PubMed ID: 10942864
[TBL] [Abstract][Full Text] [Related]
3. Using multiple decrement models to estimate risk and morbidity from specific AIDS illnesses. Multicenter AIDS Cohort Study (MACS).
Hoover DR; Peng Y; Saah AJ; Detels RR; Day RS; Phair JP
Stat Med; 1996 Nov 15-30; 15(21-22):2307-21; discussion 2337-40. PubMed ID: 8931203
[TBL] [Abstract][Full Text] [Related]
4. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and incidence of cytomegalovirus infection in patients infected with HIV-1. SEROCO group].
Robain M; Carré N; Salmon-Ceron D; Dussaix E; Meyer L
Presse Med; 1998 Jun; 27(20):949-53. PubMed ID: 9767834
[TBL] [Abstract][Full Text] [Related]
6. Projecting disease when death is likely.
Hoover DR; Peng Y; Saah AJ; Detels RR; Rinaldo CR; Phair JP
Am J Epidemiol; 1996 May; 143(9):943-52. PubMed ID: 8610708
[TBL] [Abstract][Full Text] [Related]
7. Trends of AIDS in Guadeloupe (French West Indies) a longitudinal survey from 1988 to 1997.
Deloumeaux J; Foucan L; Sow-Goerger MT; Contamin B; Strobel M
West Indian Med J; 2000 Jun; 49(2):148-53. PubMed ID: 10948855
[TBL] [Abstract][Full Text] [Related]
8. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O;
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Cox's and relative survival models when estimating the effects of prognostic factors on disease-specific mortality: a simulation study under proportional excess hazards.
Le Teuff G; Abrahamowicz M; Bolard P; Quantin C
Stat Med; 2005 Dec; 24(24):3887-909. PubMed ID: 16320267
[TBL] [Abstract][Full Text] [Related]
10. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo.
Brantsaeter AB; Liestøl K; Goplen AK; Dunlop O; Bruun JN
Scand J Infect Dis; 2002; 34(1):50-5. PubMed ID: 11874165
[TBL] [Abstract][Full Text] [Related]
11. Effect of CMV serology and CMV disease on AIDS morbidity and mortality.
Laing RB; Brettle RP; Leen CL
Infection; 1997; 25(4):255. PubMed ID: 9266268
[No Abstract] [Full Text] [Related]
12. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
Chaisson RE; Stanton DL; Gallant JE; Rucker S; Bartlett JG; Moore RD
AIDS; 1993 Jun; 7(6):857-62. PubMed ID: 8103343
[TBL] [Abstract][Full Text] [Related]
13. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
15. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
[TBL] [Abstract][Full Text] [Related]
16. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.
Coelho LE; Cardoso SW; Amancio RT; Moreira RI; Ribeiro SR; Coelho AB; Campos DP; Veloso VG; Grinsztejn B; Luz PM
BMC Infect Dis; 2016 Mar; 16():134. PubMed ID: 27001753
[TBL] [Abstract][Full Text] [Related]
17. Reduced rank proportional hazards model for competing risks.
Fiocco M; Putter H; Van Houwelingen JC
Biostatistics; 2005 Jul; 6(3):465-78. PubMed ID: 15831577
[TBL] [Abstract][Full Text] [Related]
18. Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.
Mugavero MJ; Pence BW; Whetten K; Leserman J; Swartz M; Stangl D; Thielman NM
AIDS Patient Care STDS; 2007 Sep; 21(9):681-90. PubMed ID: 17919095
[TBL] [Abstract][Full Text] [Related]
19. Validation of the alternating conditional estimation algorithm for estimation of flexible extensions of Cox's proportional hazards model with nonlinear constraints on the parameters.
Wynant W; Abrahamowicz M
Biom J; 2016 Nov; 58(6):1445-1464. PubMed ID: 27550754
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection.
Hansen KK; Vestbo J; Benfield T; Lundgren JD; Mathiesen LR
Clin Infect Dis; 1997 May; 24(5):878-83. PubMed ID: 9142786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
